期刊文献+

冠心病合并糖尿病患者糖化血红蛋白水平与心脏结构和NT-proBNP的相关性研究 被引量:7

Research on the correlation of the glycosylated haemoglobin Ale level and cardiac structure,NT-proBNP of the patients with the senile coronary heart disease and diabetes mellitus
暂未订购
导出
摘要 目的 探讨老年冠心病合并糖尿病患者糖化血红蛋白水平与心脏结构和NTproBNP的相关性.方法 选取我院门诊和内科收治的老年冠心病合并糖尿病患者120例,根据糖化血红蛋白(HbAlc)水平分为A细(HbAlc〈7%)和B组(HbA1c≥7%),利用彩色超声诊断仪进行彩色多普勒超声心动图测量心脏结构,包括室间隔舒张来期厚度(IVSTD)、左室后壁舒张末期厚度(LVPWTD)、左室舒张末期的内径(LVEDd)和舒张早期最大血流速度/舒张晚期最大血流速度(E/A),并评价心功能,射血分数(EF)和NT-pro BNP水平,比较两组上述指标的差异.结果 彩色多普勒超声心动图显示,IVSTD A组为(8.97±0.78)mm,B组为(11.32±0.64)mm,LVPWTDA组为(9.16±0.68)mm,B组为(11.45±1.64)mm,LVEDd A组为(47.23±2.09)mm,B组为(54.56±2.18)mm,B组患者的心脏结构改变程度较A组患者明显加重(P〈0.05),NT-proBNP水平B组较A组明显增高[(723±127)ng/L vs(586±138)ng/L](P〈0.05).结论 糖尿病为冠心病的易发因素,HbAlc可反映冠心病合并糖尿病患者的心脏结构改变程度,与心功能严重程度呈正相关. Objective to study the correlation of the glycosylated haemoglobin Alc level and cardiac structure, NT-proBNP of the patients with the senile coronary heart disease and diabetes mellitus.Methods Randomly selected 120 patients of senile coronary he art disease complicated with diabetes mellitus.120 patients were divided into A group(HbAlc〈7%)and B group(HbAlc≥7%)according to diglycosylated haemoglobin Alc level. Using color ultrasonic diagnostic apparatus, measured cardiac structure, such as IVSTD, LVPWTD, LVEDd, E/A, EF, and the level of NT-pro BNP, compared with these indexes. Results Color doppler echocardiography showed that IVSTD of A group was (8.97 ± 0.78) mm, B group was (11.32 ± 0.64) mm, LVPWTD of A group was(9.16 ± 0.68) mm, B group was(11.45 ± 1.64) mm, LVEDd of A group was(47.23 ± 2.09) mm, B group was(54.56 ± 2.18) mm, the cardiac structure of B group was more serious than A group (P〈0.05), the level of NT-pro BNP of B group was higher than A group [(723 ±127)ng/L vs(586 ± 138)ng/L] (P〈 0.05).Conclusion Diabetes mellitus is easy-happening factors of coronary heart disease, HbAlc can reflect the change degree of cardiac structure of coronary heart disease complicated with diahetes mellitus, it is positive correlation with severity of cardiac function.
出处 《国际医药卫生导报》 2011年第2期149-151,共3页 International Medicine and Health Guidance News
关键词 冠心病 糖尿病 糖化血红蛋白 心脏结构 NT—proBNP Coronary heart disease Diabetes mellitus The glycosylated haemoglobin Alc Cardiac structurg NT-proBNP
  • 相关文献

参考文献6

二级参考文献18

  • 1路影,杨华章.糖尿病合并高血压治疗进展[J].国外医学(内分泌学分册),2004,24(6):391-394. 被引量:33
  • 2李赟,刘江华.波动性高血糖与糖尿病大血管并发症[J].国外医学(内分泌学分册),2004,24(6):400-401. 被引量:29
  • 3Pickup JC, Mattock MB,Chusney GD, et al.NIDDM as a disease of the innate immune system:association of acute Yeactants and interlewkir-6 with metabolic syndrome X [J]. Diabetology, 1997,40(8):1286.
  • 4Bahceci M,Tuzcu A,Ogun C,et al.Is serum C-reactive protein concentration correlated with HbA1C and insulin resistance in Type 2 diabetic men with or without coronary heart disease [J]? J Endocrinol Invest,2005,28:145.
  • 5Schulze MB,Rimm EB,Li T,et al.C-reactive protein and incident cardiovascular events among men with diabetes [J].Diabetes care,2004,27:889.
  • 6Wei M,Gaskill SP,Haffner SM.Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality [J].The San Antonio Heart Study Diabetes Care ,1998,21:1167.
  • 7King DE,Mainous AG,Buchanant TA.C-reactive protein and glycemic control in adults with diabetes [J].Diabetes Care,2003,26:1535.
  • 8Ross R.Atherosclerosis an inflammatory disease [J].N Engl J Med,1999,340:115.
  • 9Ridker P M,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation is the prediction of cardiovascular disease in women [J]. New Engl Med,2000,23:836.
  • 10Danesh J,Whincup P, Walker M, et al.Low grade inflammation and coronary heart disease:prospective study and updated metaanalysis [J]. Br Med J, 2000,321:199.

共引文献59

同被引文献61

  • 1张桂林,刘尚喜,邓鹤秋,张训.晚期糖基化终产物激活内皮细胞核因子κB[J].中国动脉硬化杂志,2005,13(3):329-331. 被引量:15
  • 2李金娥,张喆,李金金.2型糖尿病合并冠心病患者血浆超敏C反应蛋白的测定及分析[J].天津医科大学学报,2005,11(4):618-620. 被引量:8
  • 3倪长霖,张亚文,胡筱芸.2型糖尿病合并冠心病危险因素的临床研究[J].天津医药,2006,34(9):607-609. 被引量:19
  • 4杨树勤.卫生统计学[M].第3版.北京:人民卫生出版社,1994,10:172-173.
  • 5陈文彬,潘祥林.诊断学[M].北京:人民卫生出版社,2006.
  • 6Lubos E,Messow CM, Schnabel R,et al. Resistin,acute cor- onary Syndrome and prognosis results from the Athero C, ene study [J]. Atherosclerosis ,2007,193( 1 ) :121.
  • 7Selvin E, Coresh J, Golden SH, et al. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communitie study[J]. Arch Intern Med, 2005,165(16) :1910.
  • 8Reilly MP,Lehrke M,Wolfe ML,et al. Resistin is an inflam- matory marker of atherosclerosis in humans[J]. Circulation,2005, 111(7) :932.
  • 9张艳.糖化血红蛋白监测对2型糖尿病并发症的影响研究[J].中国健康月刊·A版,2011,30(10):23.
  • 10中华医学会糖尿病学分会.中国糖尿病防治指南(2010版)[M].北京:北京大学医学出版社,2011.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部